Hims & Hers Health (HIMS) Return on Invested Capital (2020 - 2026)
Hims & Hers Health (HIMS) posted Return on Invested Capital of 0.03% for Q1 2026, down 129.78% sequentially from 0.1% in Q4 2024.
Hims & Hers Health (HIMS) Return on Invested Capital (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Return on Invested Capital for 6 years, with the latest figure at 0.03% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Hims & Hers Health | 7.50 Bn | 6.66 Bn | 480.80 Mn | -0.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.37% |
| Mar 31, 2026 | -0.03% |
| Dec 31, 2024 | 0.10% |
| Sep 30, 2024 | 0.05% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.02% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.03% |
| Sep 30, 2021 | -0.08% |
| Jun 30, 2021 | -1.13% |
| Mar 31, 2021 | -0.51% |
| Dec 31, 2020 | -0.10% |